T-DM1 better than standard therapy in controlling breast cancer

[News]

A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute.

More... (http://www.news-medical.net/news/20120605/T-DM1-better-than-standard-therapy-in-controlling-breast-cancer.aspx)